Rahul Nachnani

ORCID: 0000-0003-1449-2010

MedicineNeurosciencePsychologyPharmacology, Toxicology and Pharmaceutics

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Chronic Cannabigerol as an Effective Therapeutic for Cisplatin-Induced Neuropathic Pain”.

Chronic Cannabigerol as an Effective Therapeutic for Cisplatin-Induced Neuropathic Pain

Pharmaceuticals(2023)10.3390/ph16101442

N/A

0.470DataRank · unranked

22 citations

Diana E. Sepúlveda, Jennifer L. Booth, Shouhao Zhou, Nicholas Graziane, Wesley M. Raup‐Konsavage +2 more

Systematic review of drug-drug interactions of delta-9-tetrahydrocannabinol, cannabidiol, and Cannabis

Frontiers in Pharmacology(2024)10.3389/fphar.2024.1282831

N/A

0DataRank · unranked

27 citations

Amy Knehans, Jeffrey D. Neighbors, Paul T. Kocis, Tzuo Lee, Kayla Tegeler +4 more

High Cannabigerol Hemp Extract Moderates Colitis and Modulates the Microbiome in an Inflammatory Bowel Disease Model

Journal of Pharmacology and Experimental Therapeutics(2024)10.1124/jpet.124.002204

N/A

0DataRank · unranked

12 citations

Diana E. Sepúlveda, Rahul Nachnani, Alonso Cortez-Resendiz, Matthew Coates, Aviauna Beckett +4 more